Search Results 1111-1120 of 15805 for syphilis
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose ...
Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo Clinic Request Appointment Find a Doctor Locations Clinical Trials Connect to Support ...
Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...
The main purpose of this study is to evaluate the effectiveness of IONIS-TMPRSS6-LRx in reducing the frequency of phlebotomy and in improving quality of life ...
About this study. The primary aim of this study is to use an MRI-based Muscle Assessment Score (MAsS), which includes both muscle volume and fat ...
Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
Centers and Programs Center for Clinical and Translational Science (CCaTS) Education Overview Education Education Overview Certificate Program Clinical Trialist ...
Shi W, Shaw D, Walsh KG, Han X, Eden UT, Richardson RM, Gliske SV, Jacobs J, Brinkmann BH, Worrell GA, Stacey WC, Frauscher B, Thomas J, Kramer MA, Chu CJ.
Roston TM, Aghanya V, Savu A, Fordyce CB, Lawler PR, Jentzer J, Wong GC, Brunham LR, Senaratne J, van Diepen S, Kaul P. Premature Acute Myocardial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.